Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000253049, also known as SNORA43, is a small nucleolar RNA belonging to the H/ACA box class responsible for guiding pseudouridylation—a post-transcriptional modification—of specific uridines in ribosomal RNA (rRNA)[5][1]. Unlike protein-coding genes, snoRNAs do not encode proteins and are not conventional therapeutic targets such as receptors, enzymes, or transporters. There is no evidence of direct disease association, drug interaction, or use as a biomarker for SNORA43. As such, it is not considered a therapeutic target, and querying it as one is likely a mistake[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA, SNORA43 (SNORA43).